🔎 Trials Near Me

Home › Sakit ni Alzheimer › Florida › Miami

Pag-aaral pangklinika para sa Sakit ni Alzheimer sa Miami, FL

Isang pag-aaral para sa Sakit ni Alzheimer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Miami. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Nagre-recruitPhase 2
  • Clinical Site, Miami
  • Clinical Site, Miami
  • Clinical Site, Miami
  • at 1 pa
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06887192

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Nagre-recruitPhase 2
  • Allied Biomedical Research Institute (ABRI), Inc, Miami
  • South Florida Research Phase I-IV, Miami
Edad 55 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06540833

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

Nagre-recruitPhase 3
  • Nuovida Research Center, Miami
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06937229

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

Nagre-recruitPhase 4
  • Allied Biomedical Research Institute (ABRI), Inc, Miami
  • CCM Clinical Research Group, LLC, Miami
Edad 50 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07633470

Combating Alzheimer's Through Sleep and Exercise

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • University of Miami Hospitals, Miami
Edad 55 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT04855630

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Nagre-recruitPhase 2
  • BRP-Kendal Lakes, Miami
Edad 55 hanggang 85 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07589595

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Nagre-recruitPhase 3
  • Visionary Investigators Network- Neurology Aventura, Miami
Edad 50 hanggang 90 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07177352

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Nagre-recruitPhase 3
  • Local Institution - 1602, Miami
  • Local Institution - 1618, Miami
  • Hope Research Network - Miami, Miami
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07011732

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

Nagre-recruitPhase 3
  • Miami Jewish health, Miami
  • Local Institution - 2637, Miami
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07011745

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Nagre-recruitPhase 3
  • University of Miami, Miami
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06563895

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Nagre-recruitPhase 3
  • Finlay Medical Research, Miami
  • VIN-Andrew Lerman, Miami
Edad 55 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT07602582

Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.

Nagre-recruitPhase 2
  • University of Miami Department of Neurology, Miami
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update May 28, 2026 · NCT06781333

Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.

Nagre-recruitPhase 2
  • University of Miami Department of Neurology, Miami
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update May 28, 2026 · NCT07512362

[18F]PI-2620 Phase 3 Histopathological Study

Nagre-recruitPhase 3
  • Miami Jewish Health Systems, Miami
Edad 50 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT05641688

Late Onset Alzheimer's Disease

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • University of Miami, Miami
Edad 55 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT05010603

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Visionary Investigators Network, Miami
Edad 60 hanggang 90 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT06584357

Open-label Extension Study in Participants With Early Alzheimer's Disease

Nagre-recruitPhase 2
  • GSK Investigational Site, Miami
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT07105709

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

Nagre-recruit
  • Baptist Health South Florida & Florida International University, Miami
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Ene 9, 2026 · NCT03671889

Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Andrey Vyshedskiy, Miami
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 1, 2024 · NCT03657745

Longitudinal Cognitive Assessment by BoCA

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Andrey Vyshedskiy, Miami
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 1, 2024 · NCT04114994

Pag-aaral para sa Sakit ni Alzheimer sa ibang lungsod

Iba pang pag-aaral sa Miami

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.